MyChesCo on MSN32m
Traws Pharma Reports Positive Phase 1 Results for Influenza Therapy Tivoxavir MarboxilTraws Pharma, Inc. (NASDAQ: TRAW) has announced promising topline results from its Phase 1 study of tivoxavir marboxil, an ...
Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $20.25, along ...
Large pharmaceutical companies were out in force at this week’s 2024 Cell & Gene Meeting on the Mesa, as they look to expand ...
Jonathan Chang, an analyst from Leerink Partners, maintained the Buy rating on Vincerx Pharma Inc (VINC – Research Report). The ...
Skyrizi had an estimated national TV ad spend of $93.7 million — the highest amount of any brand in the top 10 during this ...
Eversana is increasing its reach across the global pharmaceutical industry. | Eversana is increasing its reach across the ...
Zealand Pharma said it has received a complete response letter from the Food and Drug Administration related to its new drug application for dasiglucagon for the prevention and treatment of ...
Stay informed with the Sun Pharma Stock Liveblog, your comprehensive resource for real-time updates and in-depth analysis of ...
The farmers clashed with police near Hakimpet, while they were on their way to the Dudyal Mandal Revenue Officer's office in ...
The US FDA has declined to approve Zealand Pharma's dasiglucagon for hypoglycaemia in infants with congenital hyperinsulinism ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback